US Biologic Presents at World Vaccine Congress

US Biologic’s CSO, Dr. Jolieke G. van Oosterwijk, presented at the World Vaccine Congress in Washington, D.C. Dr. van Oosterwijk discussed “using zoonotic disease surveillance to guide oral vaccine design” and presented the methods US Biologic uses to prevent pandemic-level diseases. In her talk, Dr. van Oosterwijk explained to the audience the unique nature of oral vaccines and US Biologic’s leadership in designing vaccines based on the animal, the disease, and the unique environments where the animals live. In these ways, US Biologic is delivering disease prevention, making the world a safer place.

Full article